Insulin facilitates monocyte migration: A possible link to tissue inflammation in insulin-resistance

Biochemical and Biophysical Research Communications

Volumn 365, Issue 3, 2008, Pages 503-508

  Kappert, Kai ^a   Meyborg, Heike ^b   Clemenz, Markus ^a   Graf, Kristof ^b   Fleck, Eckart ^b   Kintscher, Ulrich ^a   Stawowy, Philipp ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Atherosclerosis; Insulin; Matrix metalloproteinases; Monocytes; Obesity

Indexed keywords

GELATINASE B; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE;

ADIPOSE TISSUE; ARTERY WALL; ARTICLE; C57BL 6 MOUSE; CARDIOVASCULAR RISK; CELL INFILTRATION; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; HYPERINSULINEMIA; IMMUNOBLOTTING; INFLAMMATION; INSULIN RESISTANCE; LEUKEMIA CELL LINE; MALE; MONOCYTE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL;

ANIMALS; C-PEPTIDE; CELL LINE; CELL MOVEMENT; CHEMOTAXIS, LEUKOCYTE; DIET; DIETARY FATS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LEUKOCYTES, MONONUCLEAR; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; OBESITY; THIAZOLIDINEDIONES;

MUS;

EID: 36549014601     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.11.006     Document Type: Article

References (21)

1. Glowinska-Olszewska B., and Urban M. Elevated matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in obese children and adolescents. Metabolism 56 (2007) 799-805
2. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., and Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
3. Gustafson B., Hammarstedt A., Andersson C.X., and Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 2276-2283
4. Galis Z.S., Sukhova G.K., Kranzhofer R., Clark S., and Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA 92 (1995) 402-406
5. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., and Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37 (2002) 375-536
6. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., and Kaski J.C. High serum matrix metalloproteinase-9 level predict increased risk of in-hospital cardiac events in patients with type 2 diabetes and ST segment elevation myocardial infarction. Atherosclerosis (2006) 10.1016/j.atherosclerosis.2006.11.012
7. Marx N., Froehlich J., Siam L., Ittner J., Wierse G., Schmidt A., Scharnagl H., Hombach V., and Koenig W. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 283-288
8. Nigro J., Osman N., Dart A.M., and Little P.J. Insulin resistance and atherosclerosis. Endocr. Rev. 27 (2006) 242-259
9. Fischoeder A., Meyborg H., Stibenz D., Fleck E., Graf K., and Stawowy P. Insulin augments matrix metalloproteinase-9 expression in monocytes. Cardiovasc. Res. 73 (2007) 841-848
10. Pyorala M., Miettinen H., Halonen P., Laakso M., and Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 538-544
11. Grafe M., Auch-Schwelk W., Graf K., Terbeek D., Hertel H., Unkelbach M., Hildebrandt A., and Fleck E. Isolation and characterization of macrovascular and microvascular endothelial cells from human hearts. Am. J. Physiol. 267 (1994) H2138-H2148
12. Schupp M., Clemenz M., Gineste R., Witt H., Janke J., Helleboid S., Hennuyer N., Ruiz P., Unger T., Staels B., and Kintscher U. Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity. Diabetes 54 (2005) 3442-3452
13. Marx N., Walcher D., Raichle C., Aleksic M., Bach H., Grub M., Hombach V., Libby P., Zieske A., Homma S., and Strong J. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 540-545
14. Chase A.J., Bond M., Crook M.F., and Newby A.C. Role of nuclear factor-kappa B activation in metalloproteinase-1, -3, and -9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 765-771
15. Ardans J.A., Economou A.P., Martinson Jr. J.M., Zhou M., and Wahl L.M. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes. J. Leukoc. Biol. 71 (2002) 1012-1018
16. McCawley L.J., Li S., Wattenberg E.V., and Hudson L.G. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 274 (1999) 4347-4353
17. Haffner S.M., Greenberg A.S., Weston W.M., Chen H., Williams K., and Freed M.I. Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106 (2002) 679-684
18. Motomura W., Tanno S., Takahashi N., Nagamine M., Fukuda M., Kohgo Y., and Okumura T. Involvement of MEK-ERK signaling pathway in the inhibition of cell growth by troglitazone in human pancreatic cancer cells. Biochem. Biophys. Res. Commun. 332 (2005) 89-94
19. Kintscher U., Goetze S., Wakino S., Kim S., Nagpal S., Chandraratna R.A., Graf K., Fleck E., Hsueh W.A., and Law R.E. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur. J. Pharmacol. 401 (2000) 259-270
20. Shibasaki M., Takahashi K., Itou T., Bujo H., and Saito Y. A PPAR agonist improves TNF-alpha-induced insulin resistance of adipose tissue in mice. Biochem. Biophys. Res. Commun. 309 (2003) 419-424
21. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., Ranganathan G., Peterson C.A., McGehee R.E., and Kern P.A. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54 (2005) 2305-2313